Literature DB >> 28470780

Intra-institutional second opinion diagnosis can reduce unnecessary surgery for indeterminate thyroid FNA: A preliminary report on 34 cases.

C Bellevicine1, I Migliatico1, E Vigliar1, N Serra2, G Troncone1.   

Abstract

INTRODUCTION: Indeterminate diagnoses are rendered on 15%-30% of thyroid fine-needle aspirates (FNA). Thus, a second diagnostic opinion given by an outside expert pathologist is a common practice that facilitates a more appropriate clinical management. Conversely, the role of an intra-institutional second opinion diagnosis (iSOD), which is usually informally performed in-house, has not been well established.
METHODS: To assess the contribution of iSOD, a retrospective series of 34 thyroid FNA diagnosed as follicular neoplasm/suspicious follicular neoplasm (FN/SFN) with matched histological follow-up and a malignancy rate of 17.6% was selected and independently reviewed by two cytopathologists (CYT1 and 2). Cases with discrepant diagnoses were referred to a third in-house senior cytopathologist for the iSOD. The malignancy rates (MR) obtained after single independent reviews and iSOD were compared.
RESULTS: MR obtained after CYT1 and CYT2 re-screening was similar (14.28% and 19.04%, respectively) and did not improve the original MR (17.64%). Conversely, after the iSOD of discrepant diagnoses, the overall malignancy rate increased up to the 27.27%, potentially sparing unnecessary surgical procedures.
CONCLUSIONS: Intra-institutional second opinion practice for "indeterminate" thyroid FNA avoids unnecessary surgeries and maximises the detection of malignant cases diagnosed as FN/SFN.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  double slide view; follicular neoplasm/suspicious for follicular neoplasm; indeterminate; interobserver reproducibility; second opinion; thyroid fine needle aspirates

Mesh:

Year:  2017        PMID: 28470780     DOI: 10.1111/cyt.12431

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  5 in total

1.  Thy 3F and 3a malignancy rate, a multisite regional retrospective case series.

Authors:  V Alexander; J Rudd; D Walker; G Wong; A Lunt; Z Hamakarim; S Bell; A Balfour; J Davis; L Pitkin; A Pelser
Journal:  Ann R Coll Surg Engl       Date:  2018-07-03       Impact factor: 1.891

2.  Repeat Fine Needle Aspiration Cytology Refines the Selection of Thyroid Nodules for Afirma Gene Expression Classifier Testing.

Authors:  Michiya Nishino; Roselyn Mateo; Holly Kilim; Anna Feldman; Amanda Elliott; Changyu Shen; Per-Olof Hasselgren; Helen Wang; Pamela Hartzband; James V Hennessey
Journal:  Thyroid       Date:  2021-06-22       Impact factor: 6.506

3.  Predictivity of clinical, laboratory and imaging findings in diagnostic definition of palpable thyroid nodules. A multicenter prospective study.

Authors:  Maria Grazia Chiofalo; Simona Signoriello; Franco Fulciniti; Nicola Avenia; Serenella Ristagno; Celestino Pio Lombardi; Angelo Nicolosi; Maria Rosa Pelizzo; Giuliano Perigli; Andrea Polistena; Vincenzo Panebianco; Rocco Bellantone; Pietro Giorgio Calò; Isabella Merante Boschin; Benedetta Badii; Massimo Di Maio; Ciro Gallo; Francesco Perrone; Luciano Pezzullo
Journal:  Endocrine       Date:  2018-03-22       Impact factor: 3.633

4.  Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic.

Authors:  Raffaele Palladino; Ilaria Migliatico; Roberta Sgariglia; Mariantonia Nacchio; Antonino Iaccarino; Umberto Malapelle; Elena Vigliar; Domenico Salvatore; Giancarlo Troncone; Claudio Bellevicine
Journal:  Endocrine       Date:  2020-12-07       Impact factor: 3.633

5.  Outcome Assessment for a Telemedicine-Based Second Opinion Program for Midwest China.

Authors:  Ayan Mao; Yueli Meng; Qing Wang; Enhuan Du; Pei Dong; Xiaoling Yan; Kun Wang; Yujie Yang; Guangyu Hu; Wuqi Qiu
Journal:  Inquiry       Date:  2020 Jan-Dec       Impact factor: 1.730

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.